Last reviewed · How we verify

NCT04542109: READyR

REmote Assessment and Dynamic Response Intervention

Completed NA Last updated 30 June 2022
What this trial tests

NA trial testing READyR A in Dementia in 30 participants. Completed in 17 June 2022.

Timeline
27 April 2021
Primary endpoint
17 June 2022
17 June 2022

Quick facts

Lead sponsorOregon Health and Science University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment30
Start date27 April 2021
Primary completion17 June 2022
Estimated completion17 June 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Oregon Health and Science University

Who can join

62 and older, any sex, with Dementia or Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the READyR study (originally called SHARE-sense) is to redevelop and test an intervention program to remotely assess for changing dementia-related care needs.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The Remote Assessment and Dynamic Response Program: Development of an In-Home Dementia-Related Care Needs Assessment to Improve Well-Being.
    Miller LM, Solomon DN, Whitlatch CJ, Hiatt SO, et al · · 2022 · cited 4× · PMID 35402736 · DOI 10.1093/geroni/igac006
  2. Remote Passive Sensing of Older Adults' Activities and Function: User-Centered Design Considerations for Behavioral Interventions Conducted in the Home Setting.
    Miller LM, Kaye J, Lindauer A, Au-Yeung WM, et al · · 2024 · cited 3× · PMID 39423003 · DOI 10.2196/54709

Verify or expand the search:

Other recruiting trials for Dementia

Currently open trials in the same condition.

Other Oregon Health and Science University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04542109.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing